Loading…
Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
27pct
1d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Dialysis PATIENTS Demonstration Act of 2016 or the Dialysis Patient Access to Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to establish a demonstration program for the provision of integrated care to Medicare beneficiaries with end-stage renal disease (ESRD). Under the voluntary program, eligible participating providers may form organizations to offer ESRD integrated care models and serve as medical homes for program-eligible beneficiaries. Such a model: (1) shall cover medical and hospital services, other than hospice care, under Medicare; (2) must include benefits for transition into palliative care; and (3) may cover prescription drug benefits. An organization must offer at least one open network model but may also offer one or more preferred network models. An organization shall return savings achieved under the models to program-eligible beneficiaries. A beneficiary shall have the opportunity to: (1) opt out of the program, (2) make an assignment change into an open network model offered by a different organization, or (3) elect a preferred network model. The bill establishes requirements regarding: (1) benefits for program-eligible beneficiaries who are also eligible for Medicaid benefits, (2) program quality and reporting, (2) ESRD integrated care strategy, (3) program operation and scope, (4) beneficiary notification, and (5) payment.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
(1)Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (provisions related to Medicaid and Medicare) (2)Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (provisions related to Medicaid and Medicare) (3)Issues pertaining to entitlement reform, Medicare Advantage, Part D, Medicaid Dual Eligibles, the Children's Health Insurance Program (CHIP) and Medicare reimbursement and enrollment (4)Issues related to S. 2498 - Medicare Program Linking Uncoordinated Services (PLUS) Act (114th Congress) (5)Issues related to H.R.3244 - Providing Innovative Care for Complex Cases Demonstration Act of 2015 (114th Congress) (6)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2018 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2018 Call Letter (7)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Call Letter (8) Issues related to H.R. 908, the Medicare Advantage Quality Payment Relief Act (9) Issues related to S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (10) Issues related to H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes. (11) Issues related to S. 1827/H.R. 3921 - Keep Kids' Insurance Dependable and Secure Act (KIDS) Act of 2017 & H.R.3922 - Championing Healthy Kids Act (12) Issues related to H.R.5942 / S. 3090 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016
Client expense: $1,760,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
(1)Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (provisions related to Medicaid and Medicare) (2)Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (provisions related to Medicaid and Medicare) (3)Issues pertaining to entitlement reform, Medicare Advantage, Part D, Medicaid Dual Eligibles, the Children's Health Insurance Program (CHIP) and Medicare reimbursement and enrollment (4)Issues related to S. 2498 - Medicare Program Linking Uncoordinated Services (PLUS) Act (114th Congress) (5)Issues related to H.R.3244 - Providing Innovative Care for Complex Cases Demonstration Act of 2015 (114th Congress) (6)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2018 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2018 Call Letter (7)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Call Letter (8) Issues related to H.R. 908, the Medicare Advantage Quality Payment Relief Act (9) Issues related to S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (10) Issues related to H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes. (11) Issues related to S. 1827/H.R. 3921 - Keep Kids' Insurance Dependable and Secure Act (KIDS) Act of 2017 & H.R.3922 - Championing Healthy Kids Act (12) Issues related to H.R.5942 / S. 3090 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016
Client expense: $620,000 · Firm income: Not reported
2018 · fourth_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017 ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule ESRD Five Star Program charitable premium assistance Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD) S.870, CHRONIC Care Act of 2017 SNP reauthorization H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Medicare extenders package H.R. 3178, Medicare Part B Improvement Act of 2017 Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018 H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Client expense: $210,000 · Firm income: Not reported
2018 · fourth_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P); Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality, Survey and Certification Group; Issues related to charitable premium assistance for individuals with ESRD; H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017; H.R. 5942 PATIENTs Act (114th Congress); S. 870, CHRONIC Act of 2017; H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017; H.R. 2644, CKD Improvement in Research and Treatment Act of 2017; Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD); H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017; Issues related to opioid policies and offsets - H.R. 6, SUBSTANCE USE-DISORDER PREVENTION THAT PROMOTES OPIOID RECOVERY AND TREATMENT (SUPPORT) FOR PATIENTS AND COMMUNITIES ACTS. 3120: Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 S.2680 - Opioid Crisis Response Act of 2018; ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule; ESRD Five Star Program; charitable premium assistance; Skilled Nursing Facility Proposed rule (issues related to hospital discharge information)
Client expense: $210,000 · Firm income: Not reported
2018 · third_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P); Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality, Survey and Certification Group; Issues related to charitable premium assistance for individuals with ESRD; H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017; H.R. 5942 PATIENTs Act (114th Congress); S. 870, CHRONIC Act of 2017; H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017; H.R. 2644, CKD Improvement in Research and Treatment Act of 2017; Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD); H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017; Issues related to opioid policies and offsets - H.R. 6, SUBSTANCE USE-DISORDER PREVENTION THAT PROMOTES OPIOID RECOVERY AND TREATMENT (SUPPORT) FOR PATIENTS AND COMMUNITIES ACTS. 3120: Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 S.2680 - Opioid Crisis Response Act of 2018; ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule; ESRD Five Star Program; charitable premium assistance; Skilled Nursing Facility Proposed rule (issues related to hospital discharge information)
Client expense: $210,000 · Firm income: Not reported
| Democratic |
| NH |
| Barbara Comstock | Republican | VA |
| Ben Ray Luján | Democratic | NM |
| Blake Farenthold | Republican | TX |
| Bradley Byrne | Republican | AL |
| Brenda L. Lawrence | Democratic | MI |
| Candice S. Miller | Republican | MI |
| Cathy McMorris Rodgers | Republican | WA |
| Charles J. "Chuck" Fleischmann | Republican | TN |
| Charles W. Dent | Republican | PA |
| Collin C. Peterson | Democratic | MN |
| Daniel M. Donovan, Jr. | Republican | NY |
| David G. Valadao | Republican | CA |
| David Loebsack | Democratic | IA |
| David Scott | Democratic | GA |
| David W. Jolly | Republican | FL |
| David Young | Republican | IA |
| Debbie Wasserman Schultz | Democratic | FL |
| Denny Heck | Democratic | WA |
| Devin Nunes | Republican | CA |
| Diana DeGette | Democratic | CO |
| Earl Blumenauer | Democratic | OR |
| Ed Perlmutter | Democratic | CO |
| Edward R. Royce | Republican | CA |
| Eleanor Holmes Norton | Democratic | DC |
| Elijah E. Cummings | Democratic | MD |
| Eric Swalwell | Democratic | CA |
| Grace F. Napolitano | Democratic | CA |
| Henry Cuellar | Democratic | TX |
| Jackie Walorski | Republican | IN |
| Jaime Herrera Beutler | Republican | WA |
| Joe Wilson | Republican | SC |
| Joseph J. Heck | Republican | NV |
| José E. Serrano | Democratic | NY |
| Joyce Beatty | Democratic | OH |
| Julia Brownley | Democratic | CA |
| Ken Calvert | Republican | CA |
| Kurt Schrader | Democratic | OR |
| Kyrsten Sinema | Independent | AZ |
| Lois Frankel | Democratic | FL |
| Loretta Sanchez | Democratic | CA |
| Luke Messer | Republican | IN |
| Madeleine Z. Bordallo | Democratic | GU |
| Marc A. Veasey | Democratic | TX |
| Markwayne Mullin | Republican | OK |
| Marsha Blackburn | Republican | TN |
| Martha McSally | Republican | AZ |
| Martha Roby | Republican | AL |
| Matt Cartwright | Democratic | PA |
| Michelle Lujan Grisham | Democratic | NM |
| Mike Kelly | Republican | PA |
| Mike Rogers | Republican | AL |
| Patrick Meehan | Republican | PA |
| Pete Aguilar | Democratic | CA |
| Raul Ruiz | Democratic | CA |
| Rodney Davis | Republican | IL |
| Ron Kind | Democratic | WI |
| Ryan A. Costello | Republican | PA |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Steve Cohen | Democratic | TN |
| Ted Lieu | Democratic | CA |
| Terri A. Sewell | Democratic | AL |
| Tony Cárdenas | Democratic | CA |
| Wm. Lacy Clay | Democratic | MO |
| Zoe Lofgren | Democratic | CA |
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017 ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule ESRD Five Star Program charitable premium assistance Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD) S.870, CHRONIC Care Act of 2017 SNP reauthorization H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Medicare extenders package H.R. 3178, Medicare Part B Improvement Act of 2017 Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018 H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
(1)Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (provisions related to Medicaid and Medicare) (2)Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (provisions related to Medicaid and Medicare) (3)Issues pertaining to entitlement reform, Medicare Advantage, Part D, Medicaid Dual Eligibles, the Children's Health Insurance Program (CHIP) and Medicare reimbursement and enrollment (4)Issues related to S. 2498 - Medicare Program Linking Uncoordinated Services (PLUS) Act (114th Congress) (5)Issues related to H.R.3244 - Providing Innovative Care for Complex Cases Demonstration Act of 2015 (114th Congress) (6)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2018 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2018 Call Letter (7)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Call Letter (8) Issues related to H.R. 908, the Medicare Advantage Quality Payment Relief Act (9) Issues related to S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (10) Issues related to H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes. (11) Issues related to S. 1827/H.R. 3921 - Keep Kids' Insurance Dependable and Secure Act (KIDS) Act of 2017 & H.R.3922 - Championing Healthy Kids Act (12) Issues related to H.R.5942 / S. 3090 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016
Client expense: $580,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
(1)Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (provisions related to Medicaid and Medicare) (2)Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (provisions related to Medicaid and Medicare) (3)Issues pertaining to entitlement reform, Medicare Advantage, Part D, Medicaid Dual Eligibles, the Children's Health Insurance Program (CHIP) and Medicare reimbursement and enrollment (4)Issues related to S. 2498 - Medicare Program Linking Uncoordinated Services (PLUS) Act (114th Congress) (5)Issues related to H.R.3244 - Providing Innovative Care for Complex Cases Demonstration Act of 2015 (114th Congress) (6)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2018 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2018 Call Letter (7)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Call Letter (8) Issues related to H.R. 908, the Medicare Advantage Quality Payment Relief Act (9) Issues related to S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (10) Issues related to H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes. (11) Issues related to S. 1827/H.R. 3921 - Keep Kids' Insurance Dependable and Secure Act (KIDS) Act of 2017 & H.R.3922 - Championing Healthy Kids Act (12) Issues related to H.R.5942 / S. 3090 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016
Client expense: $460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2018 · second_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P); Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality, Survey and Certification Group; Issues related to charitable premium assistance for individuals with ESRD; H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017; H.R. 5942 PATIENTs Act (114th Congress); S. 870, CHRONIC Act of 2017; H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017; H.R. 2644, CKD Improvement in Research and Treatment Act of 2017; Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD); H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017; Issues related to opioid policies and offsets - H.R. 6, SUBSTANCE USE-DISORDER PREVENTION THAT PROMOTES OPIOID RECOVERY AND TREATMENT (SUPPORT) FOR PATIENTS AND COMMUNITIES ACTS. 3120: Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 S.2680 - Opioid Crisis Response Act of 2018; ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule; ESRD Five Star Program; charitable premium assistance; Skilled Nursing Facility Proposed rule (issues related to hospital discharge information)
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017 ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule ESRD Five Star Program charitable premium assistance Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD) S.870, CHRONIC Care Act of 2017 SNP reauthorization H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Medicare extenders package H.R. 3178, Medicare Part B Improvement Act of 2017 Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018 H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
(1)Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (provisions related to Medicaid and Medicare) (2)Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (provisions related to Medicaid and Medicare) (3)Issues pertaining to entitlement reform, Medicare Advantage, Part D, Medicaid Dual Eligibles, the Children's Health Insurance Program (CHIP) and Medicare reimbursement and enrollment (4)Issues related to S. 2498 - Medicare Program Linking Uncoordinated Services (PLUS) Act (114th Congress) (5)Issues related to H.R.3244 - Providing Innovative Care for Complex Cases Demonstration Act of 2015 (114th Congress) (6)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2018 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2018 Call Letter (7)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Call Letter (8) Issues related to H.R. 908, the Medicare Advantage Quality Payment Relief Act (9) Issues related to S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (10) Issues related to H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes. (11) Issues related to S. 1827/H.R. 3921 - Keep Kids' Insurance Dependable and Secure Act (KIDS) Act of 2017 & H.R.3922 - Championing Healthy Kids Act (12) Issues related to H.R.5942 / S. 3090 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016
Client expense: $580,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2018 · second_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017 ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule ESRD Five Star Program charitable premium assistance Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD) S.870, CHRONIC Care Act of 2017 SNP reauthorization H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Medicare extenders package H.R. 3178, Medicare Part B Improvement Act of 2017 Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018 H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Client expense: $310,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017 ESRD Prospective Payment System CY 2018 and Quality Incentive Program PY 2019-21 Proposed Rule ESRD Five Star Program charitable premium assistance Issues related to End Stage Renal Disease (ESRD) program and Chronic Kidney Disease (CKD) S.870, CHRONIC Care Act of 2017 SNP reauthorization H.R. 2644/S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Medicare extenders package H.R. 3178, Medicare Part B Improvement Act of 2017 Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018 H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Client expense: $310,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
(1)Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (provisions related to Medicaid and Medicare) (2)Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (provisions related to Medicaid and Medicare) (3)Issues pertaining to entitlement reform, Medicare Advantage, Part D, Medicaid Dual Eligibles, the Children's Health Insurance Program (CHIP) and Medicare reimbursement and enrollment (4)Issues related to S. 2498 - Medicare Program Linking Uncoordinated Services (PLUS) Act (114th Congress) (5)Issues related to H.R.3244 - Providing Innovative Care for Complex Cases Demonstration Act of 2015 (114th Congress) (6)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2018 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2018 Call Letter (7)Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Call Letter (8) Issues related to H.R. 908, the Medicare Advantage Quality Payment Relief Act (9) Issues related to S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (10) Issues related to H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes. (11) Issues related to S. 1827/H.R. 3921 - KIDS Act of 2017 & H.R.3922 - Championing Healthy Kids Act (12) Issues related to H.R.5942 / S. 3090 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016
Client expense: $1,310,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2017 · fourth_quarter · Medicare/Medicaid
Implementation of the Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); Implementation of the Patient Protection and Affordable Care Act (Pub. L. 111-148); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; Medicare Advantage; Senate Finance Committee Chronic Care Working Group; Integrated care legislation; Access to coverage in Health Insurance Marketplaces for ESRD; Implementation of Pub. L. 114-27, the Trade Preferences Extension Act of 2015; OCR anti-discrimination proposed and final rules; ERSD quality programs; ERSD payment rules; ESRD prospective payment system CY 2017; Quality Incentive Program PY 2020 Final Rule; CMS proposed updates to policies and payment rates for end-stage renal disease prospective payment system, quality incentive program, and payment for renal dialysis services furnished to individuals with acute kidney injury (CMS 1674-P); Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality, Survey and Certification Group; Issues related to charitable premium assistance for individuals with ESRD; H.R. 3976, the Protecting Access to Marketplace Insurance Act of 2017; H.R. 5942, the PATIENTs Act (114th Congress); S. 870, the CHRONIC Act of 2017; H.R. 3178, the Medicare Part B Improvement Act (includes H.R. 3166, dialysis factility accreditation legislation) of 2017; H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Health Issues
Implementation of the Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); Implementation of the Patient Protection and Affordable Care Act (Pub. L. 111-148); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; Medicare Advantage; Senate Finance Committee Chronic Care Working Group; Integrated care legislation; Access to coverage in Health Insurance Marketplaces for ESRD; Implementation of Pub. L. 114-27, the Trade Preferences Extension Act of 2015; OCR anti-discrimination proposed and final rules; ERSD quality programs; ERSD payment rules; ESRD prospective payment system CY 2017; Quality Incentive Program PY 2020 Final Rule; CMS proposed updates to policies and payment rates for end-stage renal disease prospective payment system, quality incentive program, and payment for renal dialysis services furnished to individuals with acute kidney injury (CMS 1674-P); Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality, Survey and Certification Group; Issues related to charitable premium assistance for individuals with ESRD; H.R. 3976, the Protecting Access to Marketplace Insurance Act of 2017; H.R. 5942, the PATIENTs Act (114th Congress); S. 870, the CHRONIC Act of 2017; H.R. 3178, the Medicare Part B Improvement Act (includes H.R. 3166, dialysis factility accreditation legislation) of 2017; H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Medicare/Medicaid
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Health Issues
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Health Issues
Implementation of the Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); Implementation of the Patient Protection and Affordable Care Act (Pub. L. 111-148); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; Medicare Advantage; Senate Finance Committee Chronic Care Working Group; Integrated care legislation; Access to coverage in Health Insurance Marketplaces for ESRD; Implementation of Pub. L. 114-27, the Trade Preferences Extension Act of 2015; OCR anti-discrimination proposed and final rules; ERSD quality programs; ERSD payment rules; ESRD prospective payment system CY 2017; Quality Incentive Program PY 2020 Final Rule; CMS proposed updates to policies and payment rates for end-stage renal disease prospective payment system, quality incentive program, and payment for renal dialysis services furnished to individuals with acute kidney injury (CMS 1674-P); Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality, Survey and Certification Group; Issues related to charitable premium assistance for individuals with ESRD; H.R. 3976, the Protecting Access to Marketplace Insurance Act of 2017; H.R. 5942, the PATIENTs Act (114th Congress); S. 870, the CHRONIC Act of 2017; H.R. 3178, the Medicare Part B Improvement Act (includes H.R. 3166, dialysis factility accreditation legislation) of 2017; H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Medicare/Medicaid
Implementation of the Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); Implementation of the Patient Protection and Affordable Care Act (Pub. L. 111-148); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; Medicare Advantage; Senate Finance Committee Chronic Care Working Group; Integrated care legislation; Access to coverage in Health Insurance Marketplaces for ESRD; Implementation of Pub. L. 114-27, the Trade Preferences Extension Act of 2015; OCR anti-discrimination proposed and final rules; ERSD quality programs; ERSD payment rules; ESRD prospective payment system CY 2017; Quality Incentive Program PY 2020 Final Rule; CMS proposed updates to policies and payment rates for end-stage renal disease prospective payment system, quality incentive program, and payment for renal dialysis services furnished to individuals with acute kidney injury (CMS 1674-P); Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality, Survey and Certification Group; Issues related to charitable premium assistance for individuals with ESRD; H.R. 3976, the Protecting Access to Marketplace Insurance Act of 2017; H.R. 5942, the PATIENTs Act (114th Congress); S. 870, the CHRONIC Act of 2017; H.R. 3178, the Medicare Part B Improvement Act (includes H.R. 3166, dialysis factility accreditation legislation) of 2017; H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Medicare/Medicaid
Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease. H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016 H.R. 5942 Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act. Issues related to H.R. 1628, the American Health Care Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Medicare/Medicaid
H.R. 5942/S. 3090 Dialysis PATIENT Demonstration Act of 2016, all provisions (bill number for 114th Congress) CMS-3317-IFC, Conditions for Coverage for End-Stage Renal Disease Facilities-Third Party Payment CMS regulations pertaining to reimbursement rates for ESRD-related services CMS survey and certification of kidney dialysis centers S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act, provisions related to end stage renal disease H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions H.R. 2556 and S. 1016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions H.R. 3178, Medicare Part B Improvement Act, all provisions S. 1729, Dialysis Access Improvement Act of 2017, all provisions H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes H.R. 3166, To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities
Client expense: $730,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2017 · third_quarter · Health Issues
H.R. 5942/S. 3090, Dialysis PATIENT Demonstration Act of 2016, all provisions (bill number for 114th Congress) CMS-3317-IFC, Conditions for Coverage for End-Stage Renal Disease (ESRD) Facilities-Third Party Payment CMS regulations pertaining to reimbursement rates for ESRD-related services CMS/Medicare Advantage ESRD rate formulation S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act, provisions related to end stage renal disease H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions H.R. 2556 and S. 1016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions H.R. 3178, Medicare Part B Improvement Act, all provisions S. 1729, Dialysis Access Improvement Act of 2017, all provisions H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes H.R. 3166, To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities
Client expense: $730,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2017 · second_quarter · Medicare/Medicaid
Issues related to H.R. 5942/S. 3090, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016 (bill number from 114th Congress)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2017 · second_quarter · Medicare/Medicaid
Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease. H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016 H.R. 5942 Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act. Issues related to H.R. 1628, the American Health Care Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Health Issues
H.R. 5942/S. 3090, Dialysis PATIENT Demonstration Act of 2016; all provisions (bill number for 114th Congress) CMS-3317-IFC, Conditions for Coverage for End-Stage Renal Disease (ESRD) Facilities-Third Party Payment H.R. 2507 The Increasing Regulatory Fairness Act; all provisions (bill number from 114th Congress) Comprehensive reforms to meaningful use; stage 3 meaningful use proposed rule CMS ESRD benchmark calculation CMS regulations pertaining to reimbursement rates for ESRD-related services CMS survey and certification of kidney dialysis centers CMS vascular care rate change proposal CMS/Medicare Advantage ESRD rate formulation S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions H.R. 2556 and S. 1016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions H.R. 3178, Medicare Part B Improvement Act, sections 201 and 202 H.R. 3168, Legislation to reauthorize Special Needs Plans, all provisions
Client expense: $1,340,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2017 · second_quarter · Medicare/Medicaid
H.R. 5942/S. 3090 Dialysis PATIENT Demonstration Act of 2016; all provisions (bill number for 114th Congress) CMS-3317-IFC, Conditions for Coverage for End-Stage Renal Disease Facilities-Third Party Payment H.R. 2507, The Increasing Regulatory Fairness Act; all provisions (bill number from 114th Congress) Comprehensive reforms to meaningful use; stage 3 meaningful use proposed rule CMS ESRD benchmark calculation CMS regulations pertaining to reimbursement rates for ESRD-related services CMS survey and certification of kidney dialysis centers CMS vascular care rate change proposal CMS/Medicare Advantage ESRD rate formulation S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions H.R. 2556 and S. 1016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions H.R. 3178, Medicare Part B Improvement Act, sections 201 and 202 H.R. 3168, Legislation to reauthorize Special Needs Plans, all provisions
Client expense: $1,340,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2017 · second_quarter · Medicare/Medicaid
Issues related to H.R. 5942/S. 3090, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016 (bill number from 114th Congress)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2017 · second_quarter · Medicare/Medicaid
Issues related to H.R. 5942/S. 3090, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016 (bill number from 114th Congress)
Client expense: Not reported · Firm income: Not reported
2017 · first_quarter · Health Issues
H.R. 5942/S. 3090 Dialysis PATIENT Demonstration Act of 2016; all provisions (bill number for 114th Congress) Conditions for Coverage for End-Stage Renal Disease (ESRD) Facilities-Third Party Payment (CMS-3317-IFC) H.R. 2507 The Increasing Regulatory Fairness Act; all provisions (bill number from 114th Congress) S. 2484 CONNECT for Health Act; all provisions (bill number from 114th Congress) Comprehensive reforms to meaningful use; stage 3 meaningful use proposed rule CMS ESRD benchmark calculation CMS regulations pertaining to reimbursement rates for ESRD-related services CMS survey and certification of kidney dialysis centers CMS vascular care rate change proposal CMS/Medicare Advantage ESRD rate formulation
Client expense: $1,050,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2017 · first_quarter · Medicare/Medicaid
H.R. 5942/S. 3090 Dialysis PATIENT Demonstration Act of 2016; all provisions (bill number for 114th Congress) Conditions for Coverage for End-Stage Renal Disease Facilities-Third Party Payment (CMS-3317-IFC) H.R. 2507 The Increasing Regulatory Fairness Act; all provisions (bill number from 114th Congress) S. 2484 CONNECT for Health Act; all provisions (bill number from 114th Congress) Comprehensive reforms to meaningful use; stage 3 meaningful use proposed rule CMS ESRD benchmark calculation CMS regulations pertaining to reimbursement rates for ESRD-related services CMS survey and certification of kidney dialysis centers CMS vascular care rate change proposal CMS/Medicare Advantage ESRD rate formulation
Client expense: $1,050,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2017 · first_quarter · Medicare/Medicaid
Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease. H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016 H.R. 5942 Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act. Issues related to H.R. 1628, the American Health Care Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Healthcare reimbursement policy. H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015. H.R. 2579, Securing Care for Seniors Act of 2015. H.R. 5659, ESRD Choice Act of 2016 H.R. 5942/S. 3090, Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016 H.R. 5506, Dialysis PATIENT Demonstration Act of 2016
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
H.R. 34, 21st Century Cures Act (Upton) - Medicare Advantage and Medicaid issues H.R. 546, ACE Kids Act (Barton) - Medicaid Childrens Care Coordination Program H.R. 588, Medicare Beneficiary Preservation of Choice Act (Rothfus-Schrader) - MA enrollment opportunities H.R. 818, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act (Roskam-Carney) - reducing fraud H.R. 1021, Protecting the Integrity of Medicare Act (Brady) - reducing fraud H.R. 2488, Medicare Beneficiary Preservation of Choice Act (Rothfus-Schrader) - MA open enrollment period H.R. 2505, Increasing Access to Data in Medicare Advantage Act (Kelly) - annual reporting of MA enrollment data H.R. 2506, Preventing Unnecessary Plan Terminations Act (Buchanan) - preventing certain MA plan terminations H.R. 2507, Increasing Regulatory Fairness Act (Brady) - schedule for MA rates H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act (Black) - Value-Based Insurance Design demonstration H.R. 2579, Securing Care for Seniors Act (Black) - MA risk adjustment model H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act (Brady) - Value-Based Insurance Design demonstration and MA open enrollment period H.R. 2582, Seniors Health Care Plan Protection Act (Buchanan) - preventing certain MA plan terminations, MA risk adjustment model H.R. 3718, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act (Roskam-Carney) - reducing fraud H.R. 3716, Ensuring Access to Quality Medicaid Providers Act (Bucshon) - oversight of terminated Medicaid providers H.R. 4275, Medicare Advantage Quality Payment Relief Act (Kelly) - calculation of MA benchmark cap H.R. 4442, CONNECT for Health Act (Black-Welch) - telehealth, remote patient monitoring services H.R. 4589, Excellence in Medicare Act (MacArthur) - MA payment cap H.R. 5273, Helping Hospitals Improve Patient Care Act (Tiberi) - MA issues, site-neutral payments H.R. 5506, Dialysis PATIENT Demonstration Act (Young) - demonstration program for Medicare beneficiaries with ESRD H.R. 5659, ESRD Choice Act (Smith) - option for ESRD patients to enroll in MA plans H.R. 5942, Dialysis PATIENTS Demonstration Act (Young) - demonstration program for Medicare beneficiaries with ESRD H.R. 6265, Medigap Reforms (McDermott) S. 298, ACE Kids Act (Grassley) - Medicaid Childrens Care Coordination Program S. 524, Comprehensive Addiction and Recovery Act (Whitehouse) - Medicare Part D lock-in programs S. 861, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act (Carper-Enzi) - reducing fraud S. 1347, Electronic Health Fairness Act - preventing certain MA plan terminations, annual reporting of MA enrollment data S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act (Thune-Stabenow) - VBID demonstration S. 1549, Care Planning Act (Warner) - advanced illness care coordination for Medicare beneficiaries S. 1913, Stopping Medication Abuse and Protecting Seniors Act (Toomey) - Medicare Part D lock-in programs S. 2104, Preserving Medicare Advantage for all Medicare Beneficiaries Act (Portman-Casey) - preventing certain MA plan terminations, MA demonstration program S. 2349, Medicare Advantage Coverage Transparency Act (Heller) - MA enrollment data S. 2484, CONNECT for Health Act (Schatz-Wicker) - telehealth, remote patient monitoring services S. 2864, RxCAP Act (Wyden) - Medicare Part D cost-sharing S. 3090, Dialysis PATIENT Demonstration Act (Heller) - demonstration program for Medicare beneficiaries with ESRD S. 3504, Chronic Care Act (Hatch-Wyden-Isakson-Warner) - chronic care reforms, Medicare Advantage provisions Regulatory Issues: Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology, network adequacy and provider directories, encounter data and other data-related issues, and audit issues; bidding and payment issues (including MA rate assumptions, MA coding intensity, MA Secondary Payer issues, Part D reinsurance, Part D low income subsidies, Part D direct and indirect remuneration (DIR), and audits); in-home health risk assessments; Medicare Medical Loss Ratio issues; implementation of sequestration under the Medicare Advantage and Part D programs; implications of the health insurer fee for MA and Part D plans; application process, audits to evaluate compliance with MA and Part D program rules, benefit design rules, enrollment rules, requirements for notice and denial forms, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff; measurement and oversight of plan performance including Special Needs Plans (SNPs); quality measures, grievance and appeals processes, fraud and abuse compliance including training; contracting issues for Dual Eligible SNPs; Federal preemption of State authority under MA and Part D programs, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, Part D coverage gap discount program, including employer group waiver plan (EGWP) issues, and other operational issues; issues raised by Part D coverage of new specialty drugs, the Part D non-interference policy and related issues (e.g., preferred pharmacy and any willing pharmacy requirements, standards for network pharmacy reimbursement, and policies regarding sponsor negotiation of pharmacy price concessions); CMS's proposed Part B drug demonstration program; Medication Therapy Management Program requirements and the Center for Medicare and Medicaid Innovation (CMMI) Demonstration; MA EGWP issues; CMMI's value-based insurance design (VBID) demonstration; Part D requirements for offering basic and enhanced alternative plans; MA and Part D systems issues affecting enrollment and disenrollment processing and payment and other operational issues; issues relating to MA and Part D Star Rating system including measures, the methodology for calculating ratings, and the role of the ratings for payment purposes; implementation of the Affordable Care Act (ACA) changes to the Part D coverage gap; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education Program; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting initiative; issues relating to Medicare coverage policy and national coverage decisions; new payment system for physicians under MACRA, including implications for MA and Part D plans; Medicare clinical trials; Medicare/Medicaid integration for dual eligibles, including implementation of the Capitated Financial Alignment Demonstration and related issues (e.g., quality ratings); Medicaid managed care regulations and policies, including CMS' proposed substantial revisions to the managed care regulations, new mental health parity rules, the Medicaid managed care actuarial soundness standard, quality oversight, Medicaid and CHIP Payment and Access Commission (MACPAC), grievance and appeals processes, fraud and abuse compliance, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including block grants, the calculation of the federal medical assistance (federal matching) percentage (FMAP), and intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost issues affecting Medicaid health plans including issues raised by Medicaid coverage of new specialty drugs; health plan-related Childrens Health Insurance Program (CHIP) issues, including eligibility and outreach issues and CHIP reauthorization; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including Medicaid managed care organization provider tax issues; standards for electronic prescribing; implementation of Medicaid changes of interest to Medicaid health plans made in the ACA including Medicaid expansion, the managed care organization (MCO) prescription drug rebate provisions, minimum payments to primary care providers (PCPs), interactions between the Medicaid program and health insurance exchanges, and Medicaid and CHIP maintenance of effort (MOE) requirements; implications of the health insurer fee for Medicaid health plans; issues related to Medicaid Managed long-term care including home and community-based waiver services (HCBS); expanding the availability of Medicare Advantage and Medicaid health plan telemedicine programs; implications of the new non-discrimination rules for health plans participating in public programs; issues related to Medigap coverage; issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); cybersecurity; provider directories; value-based insurance design models; Part D prescriber enrollment requirements; Part D recovery audit contractor programs; issues relating to enrollment of beneficiaries with ESRD into MA plans; socioeconomic status impacts on star ratings related to MA and Part D programs; and other issues relating to health care reform implementation. *Add MACPAC to Agency List.
Client expense: $1,330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Treasury, Dept of, White House Office
2016 · fourth_quarter · Health Issues
H.R. 34 21st Century Cures Act (Provisions relating to ESRD Choice Act) H.R. 5506/ H.R. 5942/S. 3090 Dialysis PATIENT Demonstration Act of 2016 (All provisions) H.R. 5659 ESRD Choice Act of 2016 (All provisions) Conditions for Coverage for End-Stage Renal Disease Facilities-Third Party Payment (CMS-3317-IFC) H.R. 270 Flexibility in Health IT Reporting Act (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) S. 776 Medication Therapy Management Empowerment Act of 2015 (All provisions) H.R. 244 MAC Transparency Act (All provisions) H.R. 2507 The Increasing Regulatory Fairness Act (All provisions) S. 2484 CONNECT for Health Act (All provisions) Comprehensive reforms to meaningful use; stage 3 meaningful use proposed rule CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services CMS survey and certification of kidney dialysis centers CMS vascular care rate change proposal CMS/Medicare Advantage ESRD rate formulation
Client expense: $720,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2016 · fourth_quarter · Medicare/Medicaid
Issues regarding care for chronic diseases, including telehealth and remote monitoring of home dialysis patients. Issues concerning reimbursement for home hemodialysis. H.R. 5659, The ESRD Choice Act of 2016, H.R. 5942, Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act of 2016; S. 3090, Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act of 2016.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015. Education related to the issue that ESRD patients have access to Medicare Advantage plans. Survey and Certification of dialysis clinics. Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease. H.R. 5506, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act. H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016. H.R. 5942 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015. Education related to the issue that ESRD patients have access to Medicare Advantage plans. Survey and Certification of dialysis clinics. Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease. H.R. 5506, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act. H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016. H.R. 5942 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease. Issues relate to H.R. 5506, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act. H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016 H.R.5942 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Survey and certification delays for dialysis facilities and policies related to Medicare payment, including H.R.5942/S.3090, the Dialysis PATIENT Demonstration Act and H.R.5659, the ESRD Choice Act of 2016, and policies related to third party payments.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
End stage renal disease (ESRD) Medicare reimbursement and payment reform. ESRD Quality measurement. Improved policies for Chronic Kidney Disease (CKD). Transplant Initiatives. Dialysis PATIENT Demonstration Act (H.R. 5506/S. 3090/H.R. 5942) ESRD Choice Act (H.R. 5659) Medicare Third Party Payment
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
End stage renal disease (ESRD) rebasing, Medicare reimbursement and payment reform. CMS's Center for Medicare and Medicaid Innovation's comprehensive ESRD Care Initiative and improving overall ESRD patient health quality. Improved policies on chronic kidney disease. Chronic care management reform legislation. ESRD Integrated Care legislation. Transplant Initiatives. Implementation of the Medicare Access and CHIP Reauthorization Act. Living Donor Protection Act (H.R. 4616/S. 2584) ESRD Choice Act (H.R. 5659) Dialysis PATIENT Demonstration Act (H.R. 5506/S. 3090/H.R. 5942) Creating High-Quality Results & Outcomes Necessary to Improve Chronic (CHRONIC) Care Act (S. 3504) 21st Century Cures Act, provisions related to ESRD coverage in Medicare Advantage Medicare Third Party Payment
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), SENATE
2016 · fourth_quarter · Medicare/Medicaid
End stage renal disease (ESRD) rebasing, Medicare reimbursement and payment reform. CMS's Center for Medicare and Medicaid Innovation's comprehensive ESRD Care Initiative and improving overall patient health quality. Improved policies on chronic kidney disease. Chronic Care management reform legislation. ESRD Integrated Care Legislation. Transplant Initiatives. Living Donor Protection Act (H.R. 4616/S. 2584) ESRD Choice Act (H.R. 5659) Dialysis PATIENT Demonstration Act (H.R. 5506/S. 3090/H.R. 5942) Implementation of the Medicare Access and CHIP Reauthorization Act Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act(S. 3504) 21st Century Cures Act, provisions related to ESRD coverage in Medicare Advantage
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
H.R. 5506 and H.R. 5659, Medicare coverage of End-Stage Renal Disease (ESRD). The ESRD Seamless Care Organizations (ESCO), and Chronic Care and Integrated Kidney Care. S. 3090, The Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act of 2016. H.R. 5942, ERSD Patient Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE